Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OLMESARTAN MEDOXOMIL Cause Colitis ulcerative? 152 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 152 reports of Colitis ulcerative have been filed in association with OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL). This represents 1.3% of all adverse event reports for OLMESARTAN MEDOXOMIL.

152
Reports of Colitis ulcerative with OLMESARTAN MEDOXOMIL
1.3%
of all OLMESARTAN MEDOXOMIL reports
0
Deaths
117
Hospitalizations

How Dangerous Is Colitis ulcerative From OLMESARTAN MEDOXOMIL?

Of the 152 reports, 117 (77.0%) required hospitalization.

Is Colitis ulcerative Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OLMESARTAN MEDOXOMIL. However, 152 reports have been filed with the FAERS database.

What Other Side Effects Does OLMESARTAN MEDOXOMIL Cause?

Sprue-like enteropathy (3,482) Gastrooesophageal reflux disease (1,819) Acute kidney injury (1,587) Weight decreased (1,569) Haemorrhoids (1,316) Diarrhoea (1,300) Hiatus hernia (938) Dizziness (885) Large intestine polyp (839) Constipation (796)

What Other Drugs Cause Colitis ulcerative?

VEDOLIZUMAB (13,455) ADALIMUMAB (6,155) INFLIXIMAB (4,785) MESALAMINE (2,427) PREDNISONE (1,496) TOFACITINIB (1,094) USTEKINUMAB (1,011) METHOTREXATE (960) ISOTRETINOIN (932) GOLIMUMAB (871)

Which OLMESARTAN MEDOXOMIL Alternatives Have Lower Colitis ulcerative Risk?

OLMESARTAN MEDOXOMIL vs OLMETEC OLMESARTAN MEDOXOMIL vs OLODATEROL OLMESARTAN MEDOXOMIL vs OLODATEROL\TIOTROPIUM OLMESARTAN MEDOXOMIL vs OLOPATADINE OLMESARTAN MEDOXOMIL vs OLUTASIDENIB

Related Pages

OLMESARTAN MEDOXOMIL Full Profile All Colitis ulcerative Reports All Drugs Causing Colitis ulcerative OLMESARTAN MEDOXOMIL Demographics